THIS INVENTOR HAS AGREED TO WAIVE THE ENTITLEMENT TO DESIGNATION,发明人放弃姓名表示权,發明人放棄姓名表示權
申请号：
TW102148993
公开号：
TWI590819B
申请日:
2013.12.30
申请国别(地区):
TW
年份:
2017
代理人:
摘要：
The present invention concerns a pharmaceutical compound having the Formula (1): or a pharmaceutically acceptable salt thereof, for use in the prevention or treatment of a cognitive, neurodegenerative or neuronal disorder or disease such as the Alzheimer Disease, a pharmaceutical composition and a method of preparing a pharmaceutical composition.本發明係有關於式(1)醫藥化合物：或其醫藥上可接受之鹽，其係用於預防或治療認知、神經退化或神經元失調或疾病，諸如阿茲海默症，一種醫藥組成物及一種製備醫藥組成物之方法。
